U.S. Food Stock News

Monolithic Power Systems, which reported stronger-than-expected Q4 2025 results and issued upbeat Q1 2026 revenue guidance of US$770 million to US$790 million, is now approaching its first-quarter 2026 earnings release on April 30 amid analyst expectations for a double-digit profit increase. Analysts’ focus on the company’s history of earnings outperformance and current positive Earnings ESP of 0.78% has heightened attention on whether Monolithic Power Systems can again exceed consensus...

CSB Bancorp (CSBB) has put up a clean set of numbers for Q1 2026, with Q4 2025 revenue at US$9.5 million, basic EPS at US$0.71, and net income of US$1.9 million anchoring the latest run of results against a trailing year where earnings grew 33.5% and net profit margin sat at 30.2%. Over recent quarters, revenue has moved from US$9.1 million in Q4 2024 to US$11.0 million in Q1 2025, US$11.5 million in Q2 2025, US$12.3 million in Q3 2025, then US$9.5 million in Q4 2025, with EPS shifting from...

ServisFirst Bancshares (SFBS) opened 2026 with Q1 results set against a strong finish to 2025, when Q4 revenue was US$152.9 million and basic EPS came in at US$1.58 on net income of US$86.4 million. Over the past year, the bank has seen revenue move from US$458.7 million in the trailing period to Q4 2024 to US$525.8 million in the trailing period to Q4 2025, with trailing EPS rising from US$4.17 to US$5.06, and earnings growth over the last 12 months reported at 21.7%. With net profit margin...

Alaska Air Group (ALK) has opened 2026 with Q1 revenue of US$3.3b and a basic EPS loss of US$1.69, compared with a trailing twelve month basic EPS of US$0.63 on revenue of US$14.4b that produced net income of US$73m. Over recent quarters, revenue has moved from US$3.1b in Q1 2025 to US$3.6b in Q4 2025 before landing at US$3.3b in the latest period. Quarterly EPS has swung from a loss of US$1.35 in Q1 2025 to a profit of US$1.45 in Q2 2025 and back to a loss in Q1 2026, leaving investors...

Northern Trust (NTRS) has opened Q1 2026 earnings season with a recent run of quarterly results that show total revenue moving from US$1,960.5 million in Q3 2024 to US$2,131.1 million in Q4 2025, alongside quarterly EPS stepping up from US$2.23 to US$2.44 over the same period. Over the last reported trailing twelve months to Q1 2026, revenue has ranged between US$7.9 billion and US$8.6 billion, with EPS running between about US$8.5 and US$10.8. This provides a basis for investors to weigh...

3M (MMM) has just opened its Q1 2026 reporting season conversation with a recent run of results that saw quarterly revenue range from US$5.95 billion to US$6.52 billion through 2025, alongside basic EPS moving between US$1.08 and US$2.05 as net income fluctuated from US$577 million to US$1.12 billion. Over the same stretch, revenue has moved from US$6.01 billion in Q4 2024 to US$6.13 billion in Q4 2025, while basic EPS shifted from US$1.34 to US$1.08. This sets a backdrop where investors are...

In April 2026, GE HealthCare and RadNet’s DeepHealth expanded their global collaboration to integrate DeepHealth’s AI-powered Breast Suite and new second-reader workflows into GE HealthCare’s Senographe Pristina and Pristina Via mammography platforms, while also showcasing advanced breast imaging technologies at the SBI 2026 Breast Cancer Imaging Symposium. This move deepens GE HealthCare’s role in AI-enabled breast cancer screening by pairing cloud-based, modular applications with its...

A ceasefire agreement in the Middle East is expected to ease geopolitical tensions and reduce near-term uncertainty. Market participants anticipate a release of delayed M&A and capital markets activity as corporate boards revisit postponed transactions. Jefferies Financial Group (NYSE:JEF) is exposed to this trend through its advisory, brokerage, and investment banking businesses. For Jefferies Financial Group, the core story centers on client activity rather than balance sheet moves or...

BOK Financial (BOKF) opened 2026 with Q1 revenue of US$553.8 million and basic EPS of US$2.59, while trailing twelve month revenue sat at US$2.23 billion and EPS at US$9.88. This provides a clear snapshot of the bank's recent earnings power. Over the past year, revenue has moved from US$2.03 billion to US$2.23 billion and trailing twelve month EPS has gone from US$8.14 to US$9.88, giving investors a cleaner read on how the income statement is scaling. With net income on a trailing basis at...

Target (TGT) is stepping further into two very different arenas at once, expanding THC hemp drink licenses in Minnesota while preparing to open six larger format stores across four states as part of its turnaround plans. See our latest analysis for Target. The recent string of collaborations and category expansions, from Pokémon merchandise to wellness brands and THC drinks, has arrived alongside a 31.43% year to date share price return and a 46.81% one year total shareholder return. The five...

RTX (RTX) opened the new year with Q1 2026 results coming on the heels of Q4 2025 revenue of US$24.2b and basic EPS of US$1.21, supported by Q4 net income of US$1.6b. Over the last six reported quarters, revenue moved from US$21.6b in Q4 2024 to US$24.2b in Q4 2025, while quarterly basic EPS ranged from US$1.10 to US$1.43. This sets up trailing twelve month EPS of US$5.02 and net income of US$6.7b as the reference point for today’s update, so the focus now is on how Q1 margins held up against...

With no single headline event setting the tone, Flowserve (FLS) is drawing interest as investors weigh its recent share performance, current valuation metrics, and the scale of its industrial flow management business. See our latest analysis for Flowserve. The share price has pulled back 1.6% over the last day to US$82.04, but a 14.9% 1 month share price return sits alongside a 99.7% 1 year total shareholder return, which suggests momentum has been strong over both shorter and longer...

Halliburton (HAL) has just opened its books on the latest period, with trailing 12 month revenue most recently sitting at about US$22.2b and basic EPS shifting from US$2.84 a year ago to US$1.50 on the most recent trailing view, setting a very different earnings backdrop for investors to interpret. Over the last reported quarters, quarterly revenue has moved between US$5,417m and US$5,697m while basic EPS has ranged from US$0.02 to around US$0.70, giving a wide spread of earnings outcomes...

On March 30, 2026, Butterfly Network announced it had secured FDA approval for its AI-powered handheld ultrasound tool that estimates gestational age to support clinicians in emergency and rural settings. This clearance highlights Butterfly’s effort to pair portable imaging hardware with embedded AI, aiming to broaden access to maternal care in underserved communities. We’ll now examine how FDA clearance of Butterfly’s gestational-age AI tool may influence its investment narrative and...

If you are wondering whether Micron Technology's current share price lines up with its underlying value, this breakdown will help you connect the recent moves in the stock with what you are actually paying for. The stock last closed at US$449.38, with returns of 6.3% over the past 30 days, a 42.5% gain year to date, and a very large return over the past year that is above 500%. Recent headlines have focused on Micron as a key name in the semiconductor space, with investors closely watching...

Why Eaton Stock Is Back in Focus After Its Data Center Move Eaton (ETN) has come back on many investors’ radar after formally creating a dedicated Data Center segment, following its US$9.5b Boyd thermal acquisition, to focus on integrated power and liquid cooling for AI data centers. See our latest analysis for Eaton. These data center announcements have come alongside a strong run in the stock, with a 30 day share price return of 14.8% and a 1 year total shareholder return of 55.4%. This...

Home Bancorp (HBCP) opened Q1 2026 reporting context around a trailing twelve month revenue base of about US$148.7 million and Basic EPS of US$5.93, backed by Q4 2025 net income of US$11.41 million on revenue of US$37.7 million. Over recent quarters, revenue has moved from US$34.1 million in Q4 2024 to US$37.7 million in Q4 2025, while quarterly Basic EPS has shifted from US$1.22 to US$1.48, supported by a net profit margin that sits at 31% versus 27.5% a year earlier and earnings growth of...

Flexsteel Industries (FLXS) has just posted its latest numbers, with recent quarterly revenue at about US$118.2 million and basic EPS of roughly US$1.24, set against trailing 12 month revenue of US$457.3 million and EPS of US$3.95 that also reflect a one off loss of US$9.6 million in the period. Over recent quarters, revenue has moved from US$104.0 million in early 2025 to US$118.2 million in the latest reported quarter. Quarterly EPS has ranged from US$0.80 to US$2.03 across that stretch,...

Mercantile Bank (MBWM) just posted another quarter of steady profitability, with Q4 2025 revenue at US$61.8 million and net income of US$22.8 million, which translates into basic EPS of US$1.40 ahead of its Q1 2026 reporting period. Over recent quarters the bank has seen revenue move from US$56.3 million in Q4 2024 to US$61.8 million in Q4 2025, while basic EPS increased from US$1.22 to US$1.40, giving investors a clear picture of consistent earnings power heading into the new year. With...

NETSTREIT (NTST) has kicked off its Q1 2026 reporting cycle with investors looking back at a steady run of quarterly numbers, including Q4 2025 revenue of US$52.7 million and basic EPS of US$0.02, supported by the REIT focused measure of Funds From Operations of US$26.6 million. Over the past year, the company has seen revenue move from US$44.1 million in Q4 2024 to US$52.7 million in Q4 2025, while basic EPS shifted from a loss of US$0.07 to a modest profit of US$0.02. This sets the backdrop...

Vicor (VICR) has reported a strong set of numbers heading into its Q1 2026 update, with Q4 2025 revenue of US$107.3 million, basic EPS of US$1.03 and trailing 12 month net income of US$118.6 million on revenue of US$407.7 million. This was accompanied by very strong year over year earnings growth that includes a one off gain of US$37.5 million. Over the last few quarters, revenue has moved from US$93.2 million in Q3 2024 to US$96.2 million in Q4 2024 and then to US$107.3 million in Q4 2025...

AbCellera Biologics recently announced that it will share interim Phase 1 data for ABCL635, its potential first-in-class non-hormonal antibody targeting the neurokinin 3 receptor for menopausal vasomotor symptoms, during its first-quarter 2026 earnings call on May 11, 2026. This update marks the first clinical readout from AbCellera’s GPCR and ion channel platform, highlighting how its transition into a clinical-stage pipeline is beginning to be tested in humans. We’ll now examine how the...

POET Technologies recently addressed a short report about U.S. tax complications linked to its passive foreign investment company status and outlined plans, including a potential U.S. headquarters move, to ease the burden on American shareholders. At the same time, the company reported audited Q4 2025 results showing a shift from development to execution, supported by over US$375.00 million of fresh financing and growing commercialization of its optical solutions for AI and hyperscale data...

In April 2026, Zymeworks Inc. presented six sets of new preclinical data at the AACR Annual Meeting, highlighting progress across its antibody-drug conjugate and novel payload programs targeting RAS-mutant and other hard-to-treat cancers. The breadth of first-in-class ADC constructs and new payload classes, including pan-RAS and mRNA translation inhibitors, underscores Zymeworks’ ambition to build a differentiated oncology technology stack rather than rely on a single lead asset. We’ll now...